OptiNose Inc

OPTN

Company Profile

  • Business description

    OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.

  • Contact

    1020 Stony Hill Road
    Suite 300
    YardleyPA19067
    USA

    T: +1 267 364-3500

    E: investors@optinose.com

    https://www.optinose.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    132

Stocks News & Analysis

stocks

2 ASX shares among our best ideas report earnings

These two shares are included on our March Global Equity Best Ideas list.
stocks

Potential moonshot investment at ASX tech leader

Investors may be over optimistic about the prospects for a new revenue source.
stocks

These ASX earnings season dogs may have fallen too far

The longer term outlook for these moated companies looks far brighter than markets seem to be giving them credit for.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,420.9057.90-0.68%
CAC 408,056.17143.54-1.75%
DAX 4022,527.01620.01-2.68%
Dow JONES (US)43,191.24649.67-1.48%
FTSE 1008,791.4279.89-0.90%
HKSE22,941.7764.50-0.28%
NASDAQ18,350.19497.09-2.64%
Nikkei 22537,331.18454.29-1.20%
NZX 50 Index12,469.7180.34-0.64%
S&P 5005,849.720.000.00%
S&P/ASX 2008,198.1047.60-0.58%
SSE Composite Index3,324.217.280.22%

Market Movers